In a statement for the record for the Senate Health, Education, Labor and Pensions (HELP) Committee hearing on how the U.S. is responding to the coronavirus, Premier underscores that Congressional action is imperative to prevent gaps in vital medical supplies in the face of emerging public health crises, such as with H1N1 and Ebola, and potentially now with coronavirus.
Additionally, Premier states that to truly address supply chain vulnerabilities, additional transparency is needed to understand the risk of supply interruption. Creating incentives for domestic manufacturing is also urgently needed to ensure a steady supply of vital drugs and medical supplies, such as N95 masks, are available for patient care. These are common-sense, market-based, holistic and sustainable solutions that Congress can enact.
